Search
for
Sort by
Research 721–750 of 1000+
- Post-Finasteride Syndrome – When will we Get the Courage to Fight the Dictating Pharma Industry – Despite Awareness of “Sexual, Neurological and Metabolic Side Effects in Young Men for Over a Decade”
- Tumor Angiogenesis and Anti-angiogenic Therapy
- A medicinal and edible formula YH0618 ameliorates the toxicity induced by Doxorubicin via regulating the expression of Bax/Bcl-2 and FOXO4
- Trailing the Path to Preventive Oncology
- A linear and reticulate crusted keratotic papulopustular eruption: a rare presentation of PRIDE (Papulopustules and/or paronychia, Regulatory abnormalities of hair growth, Itching, and Dryness due to Epidermal growth factor receptor inhibitors) complex
- Cutaneous Side Effects of Modern Targeted Therapy and Immunotherapy in Patients with Dermatological Malignancies
- Erosive Pustular Dermatosis of the Scalp-Like Eruption due to Gefitinib: Case Report and Review of the Literature of Alopecia Associated with EGFR Inhibitors
- Analysis of Data From Breast Diseases Treated With 5-Alpha Reductase Inhibitors for Benign Prostatic Hyperplasia
- The ITGB6 gene: its role in experimental and clinical biology
- Werner′s syndrome
- Non-histone Methylation of SET7/9 and its Biological Functions
- Where is the data? Delayed and chronic irAE surveillance and management after cessation of ICIs: expert insights from SITC on survivorship care and the need for long-term data
- Harnessing Milk-derived Extracellular Vesicles for Oral Drug Delivery and Therapeutic Application
- 130 Expression of nidogen1 in basal cell carcinoma
- Progress in Gelatin as Biomaterial for Tissue Engineering
- No Evidence That Human Papillomavirus Is Responsible for the Aggressive Nature of Recessive Dystrophic Epidermolysis Bullosa–Associated Squamous Cell Carcinoma
- Analysis of breast health outcomes in women on oral 5-alpha reductase inhibitors: A single-center retrospective cohort study
- EFFECTS of SOME CHEMICALS in COSMETIC PRODUCTS on PREGNANT, FETUS and NEWBORN HEALTH
- Innovations for cost-effective and eco-friendly solutions to combat chemotherapy-induced alopecia: a narrative systematic review
- GLP-1 RAs and Skin Health: Exploring Dermatologic Side Effects and Therapeutic Interventions
- BI02 (P97): Epidermal growth factor receptor inhibitor therapy induces a distinct inflammatory hair follicle response that includes a collapse of immune privilege
- Machine Learning--Enhanced Pharmacovigilance Assessment of Cardiac Adverse Events Associated With Minoxidil
- Evaluation of body dysmorphic disorder in hair loss patients and benefit after hair restoration
- Combined C3b and Factor B Autoantibodies and MPGN Type II
- Overview of Caffeine Effects on Human Health and Emerging Delivery Strategies
- Prophylaxis and Management of Skin Toxicities
- Anti-programmed cell death protein 1-induced lichenoid changes of the nail unit: Histopathologic description
- Dermoscopy of neoplastic alopecia secondary to cutaneous metastasis from breast carcinoma
- Triple Hormonal Blockade (ADT3): A Patient’s Perspective
- This Week in JAMA